Market Closed -
Nasdaq
16:30:00 2024-05-07 EDT
|
5-day change
|
1st Jan Change
|
1.4
USD
|
-6.67%
|
|
-7.89%
|
-15.15%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
68.8
|
36.51
|
24.27
|
41.19
|
45.33
|
32.36
|
Enterprise Value (EV)
1 |
-137.6
|
-140.2
|
-65.58
|
-42.43
|
-40.37
|
-66.18
|
P/E ratio
|
29.4
x
|
-0.52
x
|
-0.94
x
|
-4.72
x
|
-49
x
|
3.08
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.64
x
|
14.1
x
|
2.29
x
|
1.46
x
|
0.82
x
|
0.49
x
|
EV / Revenue
|
-1.28
x
|
-54
x
|
-6.19
x
|
-1.5
x
|
-0.73
x
|
-1
x
|
EV / EBITDA
|
-2.81
x
|
7.93
x
|
3.26
x
|
-54
x
|
-1.86
x
|
-2.3
x
|
EV / FCF
|
-3.75
x
|
12.8
x
|
0.97
x
|
2.07
x
|
4.63
x
|
8.31
x
|
FCF Yield
|
-26.7%
|
7.82%
|
103%
|
48.2%
|
21.6%
|
12%
|
Price to Book
|
0.18
x
|
0.12
x
|
0.09
x
|
0.15
x
|
0.16
x
|
0.12
x
|
Nbr of stocks (in thousands)
|
9,361
|
9,361
|
9,517
|
9,997
|
10,469
|
10,472
|
Reference price
2 |
7.350
|
3.900
|
2.550
|
4.120
|
4.330
|
3.090
|
Announcement Date
|
18-03-16
|
19-03-15
|
20-04-14
|
21-04-08
|
22-04-12
|
23-03-31
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
107.5
|
2.595
|
10.6
|
28.21
|
55.03
|
66.09
|
EBITDA
1 |
48.95
|
-17.69
|
-20.1
|
0.7862
|
21.73
|
28.74
|
EBIT
1 |
28.13
|
-35.14
|
-23.29
|
-9.683
|
9.514
|
16.48
|
Operating Margin
|
26.17%
|
-1,354.05%
|
-219.83%
|
-34.33%
|
17.29%
|
24.94%
|
Earnings before Tax (EBT)
1 |
11.56
|
-83.05
|
-22.99
|
-9.529
|
5.374
|
16.65
|
Net income
1 |
2.551
|
-69.96
|
-25.8
|
-8.42
|
-0.9247
|
10.06
|
Net margin
|
2.37%
|
-2,696.17%
|
-243.48%
|
-29.85%
|
-1.68%
|
15.22%
|
EPS
2 |
0.2500
|
-7.474
|
-2.726
|
-0.8725
|
-0.0883
|
1.002
|
Free Cash Flow
1 |
36.71
|
-10.97
|
-67.29
|
-20.47
|
-8.711
|
-7.963
|
FCF margin
|
34.14%
|
-422.73%
|
-635.02%
|
-72.56%
|
-15.83%
|
-12.05%
|
FCF Conversion (EBITDA)
|
75%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
1,438.97%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18-03-16
|
19-03-15
|
20-04-14
|
21-04-08
|
22-04-12
|
23-03-31
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
206
|
177
|
89.8
|
83.6
|
85.7
|
98.5
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
36.7
|
-11
|
-67.3
|
-20.5
|
-8.71
|
-7.96
|
ROE (net income / shareholders' equity)
|
0.7%
|
-20.7%
|
-9.26%
|
-3.12%
|
-0.33%
|
3.6%
|
ROA (Net income/ Total Assets)
|
4.67%
|
-6.4%
|
-5.04%
|
-2.11%
|
1.97%
|
3.42%
|
Assets
1 |
54.64
|
1,093
|
512
|
398.8
|
-46.96
|
294.1
|
Book Value Per Share
2 |
40.20
|
31.40
|
27.60
|
27.70
|
27.40
|
26.00
|
Cash Flow per Share
2 |
22.30
|
19.10
|
10.50
|
9.420
|
9.150
|
10.40
|
Capex
1 |
17.9
|
35.3
|
60.6
|
21.7
|
30.1
|
37.6
|
Capex / Sales
|
16.68%
|
1,359.31%
|
572%
|
77%
|
54.68%
|
56.83%
|
Announcement Date
|
18-03-16
|
19-03-15
|
20-04-14
|
21-04-08
|
22-04-12
|
23-03-31
|
|
1st Jan change
|
Capi.
|
---|
| -15.15% | 14.6M | | +4.46% | 104B | | -3.35% | 64.55B | | +46.67% | 41.5B | | +19.71% | 40.01B | | +6.70% | 33.03B | | +11.78% | 20.11B | | +17.06% | 17.52B | | +20.73% | 15.51B | | +11.69% | 15.34B |
Other Commodity Chemicals
|